1-(2-chlorophenyl)-2-hydroxypropyl-1-N-cyclopropylcarbamate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(2-chlorophenyl)-2-hydroxypropyl-1-N-cyclopropylcarbamate
• 英文别名: [(1R,2R)-1-(2-chlorophenyl)-2-hydroxypropyl] N-cyclopropylcarbamate
• 化学式: C₁₃H₁₆ClNO₃
• 分子量: 269.728
• InChiKey: QGTGCACCVVUWCZ-PELKAZGASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME
  申请人：Choi Yong Moon

  公开号：US20130005801A1

  公开（公告）日：2013-01-03

  A novel phenylcarbamate compound and a pharmaceutical composition containing the same are provided. More specifically, a novel phenylcarbamate compound, a composition for muscle relaxation containing the phenylcarbamate compound as an active ingredient, and a method of muscle relaxation comprising administering a therapeutically effective amount of the phenylcarbamate compound, are provided.

  提供了一种新的苯基氨基甲酸酯化合物和含有该化合物的药物组合物。更具体地说，提供了一种新的苯基氨基甲酸酯化合物，一种含有该苯基氨基甲酸酯化合物作为活性成分的肌肉松弛组合物，以及一种肌肉松弛方法，包括给予治疗有效量的苯基氨基甲酸酯化合物。
• PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY
  申请人：Bio-Pharm Solutions Co., Ltd.

  公开号：US20130165408A1

  公开（公告）日：2013-06-27

  A method for treatment or prevention epilepsy comprising administering a phenyl carbamate compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of epilepsy is provided.

  提供一种用于治疗或预防癫痫的方法，包括向需要治疗或预防癫痫的受试者施用一定剂量的苯基碳酸酯化合物。
• PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN
  申请人：Bio-Pharm Solutions Co., Ltd.

  公开号：US20130165409A1

  公开（公告）日：2013-06-27

  A phenyl carbamate compound; a composition for treating and/or alleviating pain containing the phenyl carbamate compound or a pharmaceutically acceptable salt thereof as an active ingredient; a method of treating and/or alleviating pain comprising administering the phenyl carbamate compound or a pharmaceutically acceptable salt thereof to a patient in need of pain treatment; and a use of the phenyl carbamate compound or a pharmaceutically acceptable salt thereof in treating and/or alleviating pain, are provided.

  提供一种苯基氨基甲酸酯化合物；一种含有该苯基氨基甲酸酯化合物或其药学上可接受的盐作为活性成分的用于治疗和/或缓解疼痛的组合物；一种治疗和/或缓解疼痛的方法，包括向需要疼痛治疗的患者施用该苯基氨基甲酸酯化合物或其药学上可接受的盐；以及利用该苯基氨基甲酸酯化合物或其药学上可接受的盐治疗和/或缓解疼痛的用途。
• PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE
  申请人：Bio-Pharm Solutions Co., Ltd.

  公开号：US20130165410A1

  公开（公告）日：2013-06-27

  A phenyl carbamate compound; a composition for treating and/or preventing stroke containing the phenyl carbamate compound or a pharmaceutically acceptable salt thereof as an active ingredient; a method of treating and/or preventing stroke comprising administering the phenyl carbamate compound or a pharmaceutically acceptable salt thereof to a patient in need of stroke treatment; and a use of the phenyl carbamate compound or a pharmaceutically acceptable salt thereof in treating and/or preventing stroke, are provided.

  本文提供了一种苯基氨基甲酸酯化合物；一种用苯基氨基甲酸酯化合物或其药学上可接受的盐作为活性成分的用于治疗和/或预防中风的组合物；一种通过向需要中风治疗的患者给予苯基氨基甲酸酯化合物或其药学上可接受的盐来治疗和/或预防中风的方法；以及一种使用苯基氨基甲酸酯化合物或其药学上可接受的盐来治疗和/或预防中风的方法。
• PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
  申请人：Bio-Pharm Solutions Co., Ltd.

  公开号：US20130165509A1

  公开（公告）日：2013-06-27

  A phenyl alkyl carbamate derivative compound and a pharmaceutical composition containing the compound are provided. More specifically, the phenyl alkyl carbamate derivative compound and a pharmaceutically acceptable salt thereof, a composition for muscle relaxation containing the phenyl alkyl carbamate derivative compounds and/or pharmaceutically acceptable salt thereof as an active ingredient, and a method of muscle relaxation comprising administering a pharmaceutically effective amount of the phenyl alkyl carbamate derivative compound and/or a pharmaceutically acceptable salt thereof to a subject in need of to a subject in need of, are provided.

  本发明提供了一种苯基烷基氨基甲酸酯衍生物化合物及其含药物组合物。更具体地，提供了苯基烷基氨基甲酸酯衍生物化合物及其药学上可接受的盐，包含苯基烷基氨基甲酸酯衍生物化合物和/或药学上可接受的盐作为活性成分的肌肉松弛剂组合物，以及通过向需要的受试者施用苯基烷基氨基甲酸酯衍生物化合物和/或药学上可接受的盐的药学有效量来实现肌肉松弛的方法。